Status:

UNKNOWN

Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients

Lead Sponsor:

University of Colorado, Denver

Collaborating Sponsors:

Children's National Research Institute

Conditions:

Trauma

Eligibility:

All Genders

31-26 years

Brief Summary

This is an observation study using the Flashback CRI T1 tablet to collect data on compensatory reserve index in pediatric trauma patients. Highest trauma activations at the institution will be enrolle...

Eligibility Criteria

Inclusion

  • • Children 31 days through 26 years (inclusive) of age who undergo Trauma Red (highest level) activation or Trauma Level 1 (mid-level) activation at Children's Hospital Colorado or Children's National Medical Center.

Exclusion

  • Pregnant patients
  • Incarcerated patients
  • Patients who object to study participation at any time
  • Limited access to or compromised monitoring sites for non-invasive finger sensors
  • Brain death (GCS 3 with fixed, dilated pupils)

Key Trial Info

Start Date :

May 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2024

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04911465

Start Date

May 1 2021

End Date

June 30 2024

Last Update

September 28 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

2

Children's National Hospital

Washington D.C., District of Columbia, United States, 20010

Continuous Assessment of Hemodynamic Compensation in Pediatric Trauma Patients | DecenTrialz